Web Analytics

Direct Enzymatic HbA1c Assay

GWB-BQK076

BQ 004-EADD

100 Tests
$264.00
Add to Cart

Description

DescriptionHemoglobin A1c is an important test recommended by the American Diabetes Association (ADA) and its usefulness was clarified by the United Kingdom Prospective Diabetes Study (UKPDS) and Diabetes Control and Clinical Trials (DCCT). Currently, the HbA1c test is recommended for patients with diabetes every 2-3 months as part of the patient Diabetes management program. Glycohemoglobin is produced by non-enzymatic addition of glucose to amino groups in hemoglobin. HBA1c refers to glucose modified hemoglobin A (HbA) specifically at N-terminal valine residues of hemoglobin beta chains. HbA1c test used both as an index of mean glycemia and as a measure of risk for the development of diabetes complications 1-3. Therefore, the HbA1c test is a good indicator of glycemic control in the preceding 2-3 months.
SpeciesHuman
Sample TypeWhole Blood samples.

Additional Information

Name Direct Enzymatic HbA1c Assay
Short Description Hemoglobin A1c is an important test recommended by the American Diabetes Association (ADA) and its usefulness was clarified by the United Kingdom Prospective Diabetes Study (UKPDS) and Diabetes Control and Clinical Trials (DCCT). Currently, the HbA1c test is recommended for patients with diabetes every 2-3 months as part of the patient Diabetes management program. Glycohemoglobin is produced by non-enzymatic addition of glucose to amino groups in hemoglobin. HBA1c refers to glucose modified hemoglobin A (HbA) specifically at N-terminal valine residues of hemoglobin beta chains. HbA1c test used both as an index of mean glycemia and as a measure of risk for the development of diabetes complications 1-3. Therefore, the HbA1c test is a good indicator of glycemic control in the preceding 2-3 months.
Datasheets / Downloads GWB-BQK076 Datasheet
Reactivity Human